Monoclonal TCR-Vβ13.1+/CD4+/NKa +/CD8-/+dim T-LGL lymphocytosis: Evidence for an antigen-driven chronic T-cell stimulation origin

Blood

Volumn 109, Issue 11, 2007, Pages 4890-4898

  Garrido, Pilar ^a   Ruiz Cabello, Francisco ^a   Bárcena, Paloma ^b,c   Sandberg, Yorick ^d   Cantón, Julia ^a   Lima, Margarida ^e   Balanzategui, Ana ^c,f   González, Marcos ^c,f   López Nevot, Miguel Angel ^a   Langerak, Anton W ^d   García Montero, Andrés C ^b,c   Almeida, Julia ^b,c   Orfao, Alberto ^b,c,g  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c CSIC   (Spain)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^f HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^g Centro de Investigacion del Cancer   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; CD4 ANTIGEN; CD8 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE STRUCTURE; GENOTYPE; HUMAN; HUMAN CELL; LYMPHOCYTOSIS; MEMBRANE TRANSPORT; NORMAL HUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; T LYMPHOCYTE; ADULT; AGED; BIOSYNTHESIS; CHEMISTRY; FEMALE; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; ANTIGENS, CD8; FEMALE; HUMANS; LYMPHOCYTOSIS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 34249743683     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-05-022277     Document Type: Article

References (37)

1. Porcu P, Baiocchi RA, Magro C. Recent developments in the biology and therapy of T-cell and natural killer-cell lymphomas. Curr Opin Oncol. 2003;15:353-362.
2. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
3. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
4. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.
5. Dhodapkar MV, Li CY, Lust JA, Tefferi A, Phyliky RL. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood. 1994;84: 1620-1627.
6. Kussick SJ, Wood BL, Sabath DE. Mature T cell leukemias which cannot be adequately classified under the new WHO classification of lymphoid neoplasms. Leukemia. 2002;16:2457-2458.
7. Burg G, Kempf W, Haeffner A, et al. From inflammation to neoplasia: new concepts in the pathogenesis of cutaneous lymphomas. Recent Results Cancer Res. 2002;160:271-280.
8. Kanchan K, Loughran TP Jr. Antigen-driven clonal T cell expansion in disorders of hematopoiesis. Leuk Res. 2003;27:291-292.
9. Wlodarski MW, O'Keefe CO, Howe EC, et al. Pathological clonal cytotoxic T cell responses - non-random nature of the T-cell receptor restriction in large granular lymphocyte leukaemia. Blood. 2005;106:2769-2780.
10. Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer. 2005;5:251-262.
11. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A. 1982;79: 2031-2035.
12. Yin CC, Medeiros LJ, Abruzzo LV, Jones D, Farhood AI, Thomazy VA. EBV-associated B and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient. Am J Clin Pathol. 2005;123:222-228.
13. Tokura Y, Yagi H, Ohshima A, et al. Cutaneous colonization with staphylococci influences the disease activity of Sezary syndrome: a potential role for bacterial superantigens. Br J Dermatol. 1995;133:6-12.
14. Linnemann T, Gellrich S, Lukowsky A, et al. Polyclonal expansion of T cells with the TCR V beta type of the tumour cell in lesions of cutaneous T-cell lymphoma: evidence for possible superantigen involvement. Br J Dermatol. 2004;150:1013-1017.
15. Wong KF, Yip SF, So CC, Lau GTC, Yeung YM. Cytomegalovirus infection associated with clonal proliferation of T-cell large granular lymphocytes: causal or casual? Cancer Genet Cytogenet. 2003;142:77-79.
16. Lamy T, Loughran TP Jr. Current concepts: large granular lymphocyte leukemia. Blood Rev. 1999; 13:230-240.
17. Melenhorst JJ, Eniafe R, Follmann D, et al. T-cell large granular lymphocyte leukemia is characterized by massive TCRBV-restricted clonal CD8 expansion and a generalized overexpression of the effector marker CD57. Hematol J. 2003;4:18-25.
18. Lima M, Almeida J, Teixeira MA, et al. TCRαβ+/ CD4+ large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorder. Am J Pathol. 2003;163:763-771.
19. Lafarge X, Merville P, Cazin MC, et al. Cytomegalovirus infection in transplant recipients resolves when circulating γδ T lymphocytes expand, suggesting a protective antiviral role. J Infect Dis. 2001;184:533-541.
20. Hadrup SR, Strindhall J, Kollgaard T, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T-cells in the very elderly. J Immunol. 2006;176:2645-2653.
21. Davey MP, Starkebaum G, Loughran TP Jr. CD3+ leukemic large granular lymphocytes utilize diverse T-cell receptor V beta genes. Blood. 1995;85:146-150.
22. O'Keefe CL, Plasilova M, Wlodarski M, et al. Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses. J Immunol. 2004;172:1960-1969.
23. + T-cells. Leukemia. 2006;20:505-513.
24. Van Dongen JJM, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations. Report of BIOMED-2 concerted action BMH4CT98-3936. Leukemia. 2003;17:2257-2317.
25. Ramal LM, de Pablo R, Guadix MJ, et al. HLA class II allele distribution in the Gypsy community of Andalusia, southern Spain. Tissue Antigens. 2001;57:138-143.
26. Flores-Villanueva PO, Hendel H, Caillat-Zueman S, et al. Associations of MHC ancestral haplotypes with resistanse susceptibility to AIDS disease development. J Immunol. 2003;170:1925-1929.
27. Van den Beemd R, Boor PP, van Lochem EG, et al. Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry. 2000;40:336-354.
28. Zaunders JJ, Wayne BD, Wang B, et al. Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, citotoxic phenotype in an HIV-1 long-term non-progressor and in CMV infection. Blood. 2004;103:2238-2247.
29. Tobin G, Thunberg U, Johnson A, et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vλ2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood. 2003;101:4952-4957.
30. Stewart-Jones GB, McMichael AJ, Bell JI, Stuart DI, Jones EY. A structural basis for immunodominant human T cell receptor recognition. Nat Immunol. 2003;4:649-650.
31. Pérez-Andrés M, Almeida J, Martín-Ayuso M, et al. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/ Th1 T cells demonstrating a squed TCR-Vbeta repertoire. Cancer. 2006;106:1296-305.
32. Porakishvili N, Kardava L, Jewell AP, et al. Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via perforin-mediated pathway. Haematologica. 2004;89:435-443.
33. Legendre CM, Forbes RD, Loertscher R, Guttmann RD, Legendre CM. CD4+/Leu-7+ large granular lymphocytes in long-term renal allograft recipients. A subset of atypical T cells. Transplantation. 1989;47:964-971.
34. null T cells clonally expanded in rheumatoid arthritis. J Immunol. 2000; 165:1138-1145.
35. O'Keefe CL, Sobecks RM, Wlodarski M, et al. Molecular TCR diagnostics can be used to identify shared clonotypes after allogeneic hamatopoietic stem cell transplantation. Exp Hematol. 2004;32:1010-1022.
36. Liu C, He M, Rooney B, Kepler TB, Chao NJ. Longitudinal analysis of T-cell receptor variable beta chain repertoire in patients with acute graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2006;12:335-345.
37. Petersson K, Forsberg G, Walse B. Interplay between superantigens and immunoreceptors. Scand J Immunol. 2004;59:345-355.